Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Measuring metaldehyde in surface waters in the UK using two monitoring approaches.

Castle GD, Mills GA, Bakir A, Gravell A, Schumacher M, Snow K, Fones GR.

Environ Sci Process Impacts. 2018 Jul 31. doi: 10.1039/c8em00180d. [Epub ahead of print]

PMID:
30062348
2.

The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management.

Girotra M, Hansen A, Farooki A, Byun DJ, Min L, Creelan BC, Callahan MK, Atkins MB, Sharon E, Antonia SJ, West P, Gravell AE; Investigational Drug Steering Committee (IDSC) Immunotherapy Task Force collaboration.

JNCI Cancer Spectr. 2018 Jul;2(3):pky021. doi: 10.1093/jncics/pky021. Epub 2018 Jul 19. Review.

3.

Calibration and application of the Chemcatcher® passive sampler for monitoring acidic herbicides in the River Exe, UK catchment.

Townsend I, Jones L, Broom M, Gravell A, Schumacher M, Fones GR, Greenwood R, Mills GA.

Environ Sci Pollut Res Int. 2018 Jun 25. doi: 10.1007/s11356-018-2556-3. [Epub ahead of print]

PMID:
29943243
4.

Calibration and field evaluation of the Chemcatcher® passive sampler for monitoring metaldehyde in surface water.

Castle GD, Mills GA, Bakir A, Gravell A, Schumacher M, Townsend I, Jones L, Greenwood R, Knott S, Fones GR.

Talanta. 2018 Mar 1;179:57-63. doi: 10.1016/j.talanta.2017.10.053. Epub 2017 Nov 22.

5.

Challenges and Opportunities in Adapting Clinical Trial Design for Immunotherapies.

Siu LL, Ivy SP, Dixon EL, Gravell AE, Reeves SA, Rosner GL.

Clin Cancer Res. 2017 Sep 1;23(17):4950-4958. doi: 10.1158/1078-0432.CCR-16-3079.

6.

A simple, low cost GC/MS method for the sub-nanogram per litre measurement of organotins in coastal water.

Cole RF, Mills GA, Bakir A, Townsend I, Gravell A, Fones GR.

MethodsX. 2016 Jul 20;3:490-6. doi: 10.1016/j.mex.2016.07.001. eCollection 2016.

7.

In Situ Calibration of a New Chemcatcher Configuration for the Determination of Polar Organic Micropollutants in Wastewater Effluent.

Petrie B, Gravell A, Mills GA, Youdan J, Barden R, Kasprzyk-Hordern B.

Environ Sci Technol. 2016 Sep 6;50(17):9469-78. doi: 10.1021/acs.est.6b02216. Epub 2016 Aug 19.

8.

An improved method for measuring metaldehyde in surface water using liquid chromatography tandem mass spectrometry.

Schumacher M, Castle G, Gravell A, Mills GA, Fones GR.

MethodsX. 2016 Mar 10;3:188-94. doi: 10.1016/j.mex.2016.03.004. eCollection 2016.

9.

Impact of the 2010 Consensus Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee.

Seymour L, Groshen S, Rosner GL, Sullivan DM, Spriggs DR, Reeves S, Gravell A, Ivy SP, Ratain MJ.

Clin Cancer Res. 2015 Nov 15;21(22):5057-63. doi: 10.1158/1078-0432.CCR-15-0035.

10.

Measurement of environmental pollutants using passive sampling devices--an updated commentary on the current state of the art.

Mills GA, Gravell A, Vrana B, Harman C, Budzinski H, Mazzella N, Ocelka T.

Environ Sci Process Impacts. 2014 Mar;16(3):369-73. doi: 10.1039/c3em00585b. Epub 2014 Jan 6. Review.

PMID:
24390685
11.

The effect of advanced treatment of sewage effluents on metal speciation and (bio)availability.

Peters A, Merrington G, Leverett D, Ellor B, Lofts S, Gravell A.

Bull Environ Contam Toxicol. 2014 Feb;92(2):248-52. doi: 10.1007/s00128-013-1143-z. Epub 2013 Nov 8.

PMID:
24201711
12.

Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents.

Dancey JE, Dobbin KK, Groshen S, Jessup JM, Hruszkewycz AH, Koehler M, Parchment R, Ratain MJ, Shankar LK, Stadler WM, True LD, Gravell A, Grever MR; Biomarkers Task Force of the NCI Investigational Drug Steering Committee.

Clin Cancer Res. 2010 Mar 15;16(6):1745-55. doi: 10.1158/1078-0432.CCR-09-2167. Epub 2010 Mar 9.

13.

Clinical trials referral resource.

Wright JJ, Zerivitz K, Gravell A.

Oncology (Williston Park). 2005 May;19(6):722, 725-6, 728 passim. No abstract available.

PMID:
15971449
14.

Clinical trials referral resource. Current clinical trials of BAY 43-9006, Part 1.

Wright JJ, Zerivitz K, Gravell A.

Oncology (Williston Park). 2005 Apr;19(4):499-502. No abstract available.

PMID:
15934518
15.

Clinical trials referral resource. Flavopiridol.

Colevas D, Blaylock B, Gravell A.

Oncology (Williston Park). 2002 Sep;16(9):1204-5, 1210-2, 1214. No abstract available.

16.

Clinical trials referral resource. Current clinical trials of R115777 (Zarnestra).

Wright JJ, Zerivitz K, Gravell AE, Cheson BD.

Oncology (Williston Park). 2002 Jul;16(7):930-1, 935-7. No abstract available.

17.

Clinical trials referral resource. Current clinical trials of fenretinide.

Swerdlow RD, Zwiebel JA, Gravell AE, Cheson BD.

Oncology (Williston Park). 2001 Dec;15(12):1595-6, 1598, 1600. No abstract available.

18.

Clinical trials referral resource. ST1571.

Murgo A, Wood KF, Gravell AE, Cheson BD.

Oncology (Williston Park). 2001 Jul;15(7):881-2, 885-6. No abstract available.

19.

Movement of petroleum hydrocarbons in sandy coastal soils.

Daniels R, Davies J, Gravell A, Rowland P.

J Environ Monit. 2000 Dec;2(6):645-50.

PMID:
11296755
20.

Clinical trials referral resource. Current cooperative group phase III clinical trials in early-stage breast cancer.

Abrams J, Gravell A, Cheson B.

Oncology (Williston Park). 2001 Feb;15(2):176-7, 181-2, 185. No abstract available. Erratum in: Oncology (Huntingt) 2001 Apr;15(4):466.

Supplemental Content

Loading ...
Support Center